000 01678 a2200493 4500
005 20250510205833.0
264 0 _c19751108
008 197511s 0 0 eng d
022 _a0022-5347
024 7 _a10.1016/s0022-5347(17)59589-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBaker, H W
245 0 0 _aThe assessment of results following endocrine therapy for prostatic cancer.
_h[electronic resource]
260 _bThe Journal of urology
_cJun 1975
300 _a824-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aChlorotrianisene
_xtherapeutic use
650 0 4 _aDiethylstilbestrol
_xtherapeutic use
650 0 4 _aDrug Evaluation
650 0 4 _aEdema
_xchemically induced
650 0 4 _aFollicle Stimulating Hormone
_xblood
650 0 4 _aGynecomastia
_xchemically induced
650 0 4 _aHeart Failure
_xchemically induced
650 0 4 _aHemiplegia
_xchemically induced
650 0 4 _aHumans
650 0 4 _aLuteinizing Hormone
_xblood
650 0 4 _aMale
650 0 4 _aNausea
_xchemically induced
650 0 4 _aPalliative Care
650 0 4 _aProstate
_xsurgery
650 0 4 _aProstatic Neoplasms
_xblood
650 0 4 _aPulmonary Embolism
_xchemically induced
650 0 4 _aTestis
_xsurgery
650 0 4 _aTestosterone
_xblood
650 0 4 _aUreter
_xsurgery
650 0 4 _aUrinary Bladder Neck Obstruction
_xtherapy
700 1 _aBurger, H G
700 1 _ade Kretser, D M
700 1 _aHudson, B
700 1 _aRennie, G C
700 1 _aStraffon, W G
773 0 _tThe Journal of urology
_gvol. 113
_gno. 6
_gp. 824-8
856 4 0 _uhttps://doi.org/10.1016/s0022-5347(17)59589-0
_zAvailable from publisher's website
999 _c49380
_d49380